We hypothesize that Zol stimulation may upregulate co-stimulatory monocytes CD40, CD80, and CD1d molecules, which in turn, enhance IL-4 secretion by CD1d-restricted lipid antigen responsive Vδ1+ T cells in the PB of SSc patients (43, 44). Here, CD40 is linked to systemic sclerosis.